Single-institution validation of the international consensus guidelines for treatment of branch duct intraductal papillary mucinous neoplasms of the pancreas.
about
Management of Incidental Pancreatic Cystic LesionsCystic neoplasms of the pancreas.Plectin-1 is a biomarker of malignant pancreatic intraductal papillary mucinous neoplasms.Natural history of branch duct intraductal papillary mucinous neoplasm with mural nodules: a Japan Pancreas Society multicenter studyInternational Consensus Guidelines parameters for the prediction of malignancy in intraductal papillary mucinous neoplasm are not properly weighted and are not cumulative.Smoking is not associated with severe dysplasia or invasive carcinoma in resected intraductal papillary mucinous neoplasms.The use of protein-based biomarkers for the diagnosis of cystic tumors of the pancreasCytological analysis of small branch-duct intraductal papillary mucinous neoplasms provides a more accurate risk assessment of malignancy than symptoms.Validation of international consensus guideline 2012 for intraductal papillary mucinous neoplasm of pancreas.Determining the natural history of pancreatic cystic neoplasms: a Manitoban cohort studyWhat Is the Best Way to Identify Malignant Transformation Within Pancreatic IPMN: A Systematic Review and Meta-Analyses.Cytology adds value to imaging studies for risk assessment of malignancy in pancreatic mucinous cysts.Utility of the 2006 Sendai and 2012 Fukuoka guidelines for the management of intraductal papillary mucinous neoplasm of the pancreas: A single-center experience with 138 surgically treated patientsUtility of the sendai consensus guidelines for branch-duct intraductal papillary mucinous neoplasms: a systematic review.The role of cytopathology and cyst fluid analysis in the preoperative diagnosis and management of pancreatic cysts >3 cm.A large mural nodule in branch duct intraductal papillary mucinous adenoma of the pancreas: a case report.Validity of the management strategy for intraductal papillary mucinous neoplasm advocated by the international consensus guidelines 2012: a retrospective review.Novel Biomarkers for Pancreatic Cysts.Cystic pancreatic lesions: From increased diagnosis rate to new dilemmas.Development and Validation of a Multi-Institutional Preoperative Nomogram for Predicting Grade of Dysplasia in Intraductal Papillary Mucinous Neoplasms (IPMNs) of the Pancreas: A Report from The Pancreatic Surgery Consortium.Pancreatic Cysts and Guidelines.Clinicopathological Meaning of Size of Main-Duct Dilatation in Intraductal Papillary Mucinous Neoplasm of Pancreas: Proposal of a Simplified Morphological Classification Based on the Investigation on the Size of Main Pancreatic Duct.A MicroRNA Panel in Pancreatic Cyst Fluid for the Risk Stratification of Pancreatic Cysts in a Prospective Cohort.mAb Das-1 is specific for high-risk and malignant intraductal papillary mucinous neoplasm (IPMN).High-grade dysplasia and adenocarcinoma are frequent in side-branch intraductal papillary mucinous neoplasm measuring less than 3 cm on endoscopic ultrasound.Natural courses of branch duct intraductal papillary mucinous neoplasm.Implications of imaging criteria for the management and treatment of intraductal papillary mucinous neoplasms - benign versus malignant findings.Diagnostic performance and imaging features for predicting the malignant potential of intraductal papillary mucinous neoplasm of the pancreas: a comparison of EUS, contrast-enhanced CT and MRI.Are the Sendai and Fukuoka consensus guidelines for cystic mucinous neoplasms of the pancreas useful in the initial triage of all suspected pancreatic cystic neoplasms? A single-institution experience with 317 surgically-treated patients.Validation of international consensus guidelines for the resection of branch duct-type intraductal papillary mucinous neoplasms.Revised international consensus guidelines for the management of patients with mucinous cysts.Effect of a region-wide incorporation of an algorithm based on the 2012 international consensus guideline on the practice pattern for the management of pancreatic cystic neoplasms in an integrated health system
P2860
Q26796503-8B41CABE-2C63-4276-908A-43F6F7A44972Q30415099-B4085FCC-1510-421C-827F-2A4B4037A75BQ30416761-F27842F5-988D-4018-A8A7-5962803FA3D7Q34387750-298CE6A6-1CD7-4129-AA99-13B746EAF753Q34548931-6CE615D3-7BF1-43FE-8940-5FC211964052Q35187065-EE9719D8-12ED-4CD9-B00B-A80F243866F5Q35450240-71E26206-67FF-43AD-8E51-25656BF2588AQ35589994-D5ACD0D9-861E-46A1-9926-D32FC901D2CBQ36637238-FD3EB782-FD1C-4016-B519-CC03229C2095Q36747331-0555462B-3EB2-463E-91F0-D9A793A4AFE6Q36751497-89766963-8E6F-4961-AE09-027F828F0AE9Q37279909-60E3CDC9-C9DC-4ED2-ABB1-43A2E4897386Q37300662-0767C690-88C0-45F6-B567-E1B8AA8ECB70Q38199398-3A9356EF-1DC6-49AF-8251-3F814A04ABA3Q38232034-579A8025-43A9-44CD-B12D-5764B796ED1AQ38326719-532F992F-BC8C-432F-89AB-EEED2AAFBA1FQ38675020-9EA63BAA-FE66-4D37-8816-088768191207Q38757526-6FA499D3-FFA1-4A35-A27B-96362BA81D84Q39007085-ED39C02E-9260-4AC0-B4CF-E0E087E92CDAQ39025112-0A183B0C-5CA3-4FE8-9E21-33B928FAAD91Q39320253-09F079AC-64A0-4DA3-82C4-84DA2232C1B6Q41039235-9513E1F6-76AD-4497-A262-DDE9EE6632BCQ41093183-36F093A3-B162-4326-8FC2-7F3FA606E070Q41688814-C1A4FD4D-478F-4F1D-8764-8256DF573C21Q43418185-0FB1B268-74E5-4F24-B5C4-D68691598382Q48169264-F8762F42-6D87-4DBB-BCF6-ED6088C15460Q52871912-006C027E-DF28-4B64-819E-06BD4CFDB911Q52953175-76E03D29-90A2-492C-AC2D-466E156BE3EEQ53080380-B0937B30-A65A-498D-83F5-BEC535963E73Q53092810-6CECC5B8-9138-4785-9175-D054A522D7EAQ53122657-48AF717F-441A-4F29-A391-FC5363D13616Q59133433-E1EC233B-96F4-4C49-877E-8E8B4B6E1983
P2860
Single-institution validation of the international consensus guidelines for treatment of branch duct intraductal papillary mucinous neoplasms of the pancreas.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Single-institution validation ...... ous neoplasms of the pancreas.
@en
Single-institution validation ...... ous neoplasms of the pancreas.
@nl
type
label
Single-institution validation ...... ous neoplasms of the pancreas.
@en
Single-institution validation ...... ous neoplasms of the pancreas.
@nl
prefLabel
Single-institution validation ...... ous neoplasms of the pancreas.
@en
Single-institution validation ...... ous neoplasms of the pancreas.
@nl
P2093
P1476
Single-institution validation ...... ous neoplasms of the pancreas.
@en
P2093
Atsushi Kida
Kazuyuki Nagai
Kohei Ogawa
Masayuki Koizumi
Shinji Uemoto
Tatsuo Ito
Toshihiko Masui
Yoshiya Kawaguchi
P304
P356
10.1007/S00534-009-0068-8
P577
2009-03-12T00:00:00Z